Medtronic (MDT) Q3 2026 Earnings
Medtronic reported Q3 2026 revenue of $9.0B (+8.7% YoY), beat analyst consensus of $8.9B by $106.1M. Diluted EPS came in at $1.36 (-2.2% YoY), beat the $1.34 consensus by $0.02. Medtronic reports across 4 business segments, led by Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
Financial Snapshot
Trailing eight quarters through Q3 2026
Q3 2026 Earnings FAQ
Common questions about Medtronic's Q3 2026 earnings report.
Medtronic (MDT) reported Q3 2026 earnings on February 17, 2026 before market open.
Medtronic reported revenue of $9.0B and diluted EPS of $1.36 for Q3 2026.
Revenue beat the consensus estimate of $8.9B by $106.1M. EPS beat the consensus estimate of $1.34 by $0.02.
Compared to the same quarter a year prior, revenue grew 8.7% from $8.3B a year earlier and diluted EPS declined 2.2% from $1.39.
You can read the 8-K earnings release (0001628280-26-008300) and the 10-Q periodic report (0001628280-26-011107) directly on SEC EDGAR. The filing index links above go to sec.gov.